Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ocular Oncology
•
Ophthalmology
•
Cornea and External Disease
How do you determine the role of adjunctive therapies for a patient with conjunctival squamous cell carcinoma (SCC) that has recurred after initial surgical excision?
Related Questions
How do you decide on treatment modality for ocular surface squamous neoplasia?
What factors influence the decision to initiate anti-VEGF injections to prevent radiation retinopathy after plaque brachytherapy?
How do you approach IOL exchange in a patient who is unhappy after cataract surgery with a premium IOL?
When should amblyopia treatment be initiated in patients being treated for retinoblastoma?
How do approach perioperative steroids for a quiescent uveitis patient undergoing cataract surgery?
In patients with sicca symptoms and positive SSA/SSB how often do you perform other diagnostic testing such as salivary gland ultrasound, biopsy, Shirmers, ocular staining, stimulated salivary flow, etc?
What dose would you use for a plaque brachytherapy for a melanoma involving the iris?
How do you manage a situation where the lens optic shifts in front of the iris after a Yamane technique?
What factors should be considered when deciding whether to perform corneal crosslinking (CXL) in mild cases of keratoconus?
How would you approach the management of dry corneal melt in a patient requiring high dose systemic steroids and no apparent underlying systemic autoimmune disease?
